Cargando…
Post-Marketing Surveillance of a generic Oxaliplatin (Alvoxal(Ⓡ)) in Iranian Patients with Cancer
BACKGROUND: CRC is the second and third most common cancer in women and men, respectively. The national comprehensive cancer network guidelines recommend oxaliplatin-based chemotherapy as a preferred regimen for patients with advanced or metastatic colon cancer. Oxaliplatin is also used in the off-l...
Autores principales: | Shahi, Farhad, Gorji, Mojtaba, Payandeh, Mehrdad, Rezvani, Hamid, Vaezi, Mohammad, Seifi, Sharareh, Baari, Alireza, Khalili-Dizaji, Reza, Hashemi, Seyed Mehdi, Salimi, Saeid, Kamranzadeh, Hosein, Shazad, Babak, Salari, Sina, Dameshghi, Davoud Oulad, Sarkheil, Mehdi, Mirzania, Mehrzad, Anjidani, Nassim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732752/ https://www.ncbi.nlm.nih.gov/pubmed/35024073 http://dx.doi.org/10.1016/j.curtheres.2021.100657 |
Ejemplares similares
-
ABO Incompatibility and Hematopoietic Stem Cell Transplantation Outcomes
por: Vaezi, Mohammad, et al.
Publicado: (2017) -
A patient with Multiple myeloma and Renal cell carcinoma
por: Shahi, Farhad, et al.
Publicado: (2016) -
Approach to the Triple Negative Breast Cancer in New Drugs Area
por: Mirzania, Mehrzad
Publicado: (2016) -
Assessing the prognostic factors, survival, and recurrence incidence of triple negative breast cancer patients, a single center study in Iran
por: Mousavi, Seied Asadollah, et al.
Publicado: (2019) -
A Post-Marketing Surveillance Study to Evaluate the Safety Profile of Alvotere(Ⓡ) (Docetaxel) in Iranian Patients Diagnosed with Different Types of Cancers Receiving Chemotherapy
por: Shahi, Farhad, et al.
Publicado: (2021)